William Weber

All articles by William Weber

TRT System Now Indicated for AKI Patients

FlowMedica, Inc., of Fremont, Calif., announced that it has received clearance for a new labeling indication for its Benephit Infusion Systems, which can now facilitate targeted renal therapy (TRT) in patients who have demonstrated symptoms of or are at risk of developing acute kidney injury (AKI).

Pre-Mixed Drug for Hyponatremia Okayed

Vaprisol (conivaptan hydrochloride injection) Premixed in 5% Dextrose, a new formulation of Vaprisol developed by Astellas Pharma US, Inc., has been approved for the treatment of both euvolemic and hypervolemic hyponatremia in hospitalized patients.

Next post in FDA News